Premium
Guest Editorial: Knowledge transfer and the path of translational medicine
Author(s) -
Childs Charmaine
Publication year - 2010
Publication title -
nursing and health sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.563
H-Index - 47
eISSN - 1442-2018
pISSN - 1441-0745
DOI - 10.1111/j.1442-2018.2010.00546.x
Subject(s) - translational medicine , biomedicine , translational science , bench to bedside , translational research , alternative medicine , health care , medicine , engineering ethics , bridge (graph theory) , medical education , political science , bioinformatics , engineering , pathology , law , medical physics , biology
Translational medicine is at the forefront of academic health care. Although readers might recognize the term, few will be familiar with the principles of this emerging discipline. For many years, clinicians and scientists were concerned that discovery and innovation in cutting‐edge science and biomedicine were not being used to cure or treat patients. This “problem” fostered a new academic paradigm, the aims being to develop a pathway to bridge the preclinical to clinical care interface and, ultimately, to bring treatments and therapies to the real world of patients and of health‐care providers. There are three integrated “phases” of the “bench‐to‐bedside” translational medicine journey. A brief introduction to the discipline of translational medicine is presented.